Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan

MLA

Syuntaro Higashi, et al. “Clinical Efficacy of Adalimumab in Crohn’s Disease: A Real Practice Observational Study in Japan.” BMC Gastroenterology, vol. 16, July 2016. EBSCOhost, https://doi.org/10.1186/s12876-016-0501-9.

APA

Syuntaro Higashi, Fuminao Takeshima, Masato Ueno, Daisuke Yoshikawa, Yuko Akazawa, Ken Ohnita, Kayoko Matsushima, Tomohito Morisaki, Hidetoshi Oda, Hajime Isomoto, Naoyuki Yamaguchi, Maho Ikeda, Kazuhiko Nakao, Haruhisa Machida, & Hitomi Minami. (2016). Clinical efficacy of adalimumab in Crohn’s disease: a real practice observational study in Japan. BMC Gastroenterology, 16. https://doi.org/10.1186/s12876-016-0501-9

Chicago

Syuntaro Higashi, Fuminao Takeshima, Masato Ueno, Daisuke Yoshikawa, Yuko Akazawa, Ken Ohnita, Kayoko Matsushima, et al. 2016. “Clinical Efficacy of Adalimumab in Crohn’s Disease: A Real Practice Observational Study in Japan.” BMC Gastroenterology 16 (July). doi:10.1186/s12876-016-0501-9.